腹腔镜Kasai术中肝中动脉离断的前瞻性队列研究
本研究前瞻性纳入116例III型胆道闭锁患儿,其中92例术中可见肝中动脉并分为离断组(n=54)和保留组(n=38)。结果显示离断组手术时间显著缩短,两组在肝功能、胆管炎发生率、黄疸清除率及2年自体肝生存率上无显著差异,短期安全性良好。
要点
- 肝中动脉离断可缩短腹腔镜Kasai手术时间。
- 离断组未出现肝IV段缺血或坏死。
- 两组胆管炎发生率、黄疸清除率及2年自体肝生存率无显著差异。
核心结论
- 肝中动脉离断在腹腔镜Kasai术中短期安全性良好,未检测到肝IV段缺血或坏死。
- 该操作便于肝门解剖,与更短的手术时间相关,支持其临床适用性。
研究设计与样本
- 前瞻性队列研究,纳入2014年1月至2024年5月在淮安市妇幼保健院接受腹腔镜Kasai术的116例III型胆道闭锁患儿。
- 最终分析92例(79.3%)术中可见肝中动脉的患儿,分为离断组(n=54)和保留组(n=38)。
主要发现
- 离断组手术时间显著短于保留组[(195.5±15.0)min vs.(228.7±20.5)min,P<0.001]。
- 两组术中出血量、术后经口喂养时间和住院时间均无显著差异(均P>0.05)。
- 两组术前及术后1、2、6个月ALT、AST、TBIL、DBIL均无显著差异(均P>0.05)。
- 术后6个月胆管炎发生率:离断组10例,保留组6例(p=0.734)。
- 6个月黄疸清除率:离断组70.3%,保留组73.6%(P=0.728);2年自体肝生存率:离断组66.6%,保留组68.4%(P=0.860)。
临床怎么用
- 在腹腔镜Kasai术中,若肝中动脉影响肝门解剖,可考虑离断以缩短手术时间。
- 离断肝中动脉后需关注肝IV段血供,但本队列未出现缺血或坏死。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the clinical significance of middle hepatic artery (MHA) transection during laparoscopic Kasai portoenterostomy (KPE) in children with type III biliary atresia (BA). METHODS: This prospective cohort study enrolled 116 consecutive children with type III BA who underwent laparoscopic KPE at Huai'an Maternal and Child Health Care Hospital between January 2014 and May 2024. Among them, 92 (79.3%) patients with an intraoperatively visible MHA were included in the final analysis, and divided into two groups: the MHA transection group (n=54) and the MHA preservation group (n=38). Perioperative parameters and long-term follow-up outcomes were prospectively collected and compared between the two groups. RESULTS: No statistically significant differences were noted between the two groups in terms of sex distribution, age at surgery, or body weight (all P>0.05). The operation time was significantly shorter in the MHA transection group than in the MHA preservation group [(195.5±15.0) min vs. (228.7±20.5) min, P<0.001]. There were no significant differences in intraoperative blood loss, postoperative oral feeding time, and hospital stay between the two groups (all P > 0.05). In terms of hepatic function parameters, no significant between-group differences were observed in preoperative alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin (TBIL), and direct bilirubin (DBIL) (all P > 0.05). Similarly, no significant between‑group differences were observed in ALT, AST, TBIL, or DBIL at 1‑, 2‑, and 6‑month postoperatively (all P > 0.05). Six months after surgery, cholangitis developed in 10 cases of the MHA transection group and 6 cases of the MHA preservation group (p=0.734). The 6-month jaundice clearance rate was 70.3% in the MHA transection group and 73.6% in the MHA preservation group (P=0.728), and the 2-year native liver survival rate was 66.6 and 68.4%, respectively (P=0.860), with no statistically significant differences. CONCLUSION: The results from our cohort demonstrated that MHA transection was relatively safe in the short term, with no instances of hepatic segment IV ischemia or necrosis detected. As it facilitated hilar dissection, this maneuver was associated with shorter operative time, lending support to the clinical applicability of MHA transection.
引用
- Zhu S, Li B, Liu Z, et al. Middle hepatic artery transection in laparoscopic Kasai portoenterostomy for Type III biliary atresia: a prospective cohort study. Surg Endosc. 2026. PMID: 42778780. doi:10.1007/s00464-026-13393-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。